PMC:7029448 / 7496-7940 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"132","span":{"begin":88,"end":97},"obj":"Species"},{"id":"133","span":{"begin":277,"end":283},"obj":"Chemical"}],"attributes":[{"id":"A132","pred":"tao:has_database_id","subj":"132","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"For the biosafety-level (BSL) applied for inactivation of clinical samples suspected of 2019-nCoV, 22 laboratories of the 47 EU/EEA laboratories indicated to do this at BSL2. Twenty-one laboratories indicated to do so at BSL3. Four laboratories indicated an intermediate level BSL2 + (BSL2 with extra precautions such as wearing a filtering face piece (FFP)2 mask). Different approaches were observed between laboratories within some countries."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T11","span":{"begin":341,"end":345},"obj":"Body_part"}],"attributes":[{"id":"A11","pred":"fma_id","subj":"T11","obj":"http://purl.org/sig/ont/fma/fma24728"}],"text":"For the biosafety-level (BSL) applied for inactivation of clinical samples suspected of 2019-nCoV, 22 laboratories of the 47 EU/EEA laboratories indicated to do this at BSL2. Twenty-one laboratories indicated to do so at BSL3. Four laboratories indicated an intermediate level BSL2 + (BSL2 with extra precautions such as wearing a filtering face piece (FFP)2 mask). Different approaches were observed between laboratories within some countries."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T5","span":{"begin":341,"end":345},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0001456"}],"text":"For the biosafety-level (BSL) applied for inactivation of clinical samples suspected of 2019-nCoV, 22 laboratories of the 47 EU/EEA laboratories indicated to do this at BSL2. Twenty-one laboratories indicated to do so at BSL3. Four laboratories indicated an intermediate level BSL2 + (BSL2 with extra precautions such as wearing a filtering face piece (FFP)2 mask). Different approaches were observed between laboratories within some countries."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T59","span":{"begin":99,"end":101},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T60","span":{"begin":329,"end":330},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T61","span":{"begin":341,"end":345},"obj":"http://purl.obolibrary.org/obo/UBERON_0001456"}],"text":"For the biosafety-level (BSL) applied for inactivation of clinical samples suspected of 2019-nCoV, 22 laboratories of the 47 EU/EEA laboratories indicated to do this at BSL2. Twenty-one laboratories indicated to do so at BSL3. Four laboratories indicated an intermediate level BSL2 + (BSL2 with extra precautions such as wearing a filtering face piece (FFP)2 mask). Different approaches were observed between laboratories within some countries."}

{"project":"LitCovid-sentences","denotations":[{"id":"T58","span":{"begin":0,"end":174},"obj":"Sentence"},{"id":"T59","span":{"begin":175,"end":226},"obj":"Sentence"},{"id":"T60","span":{"begin":227,"end":365},"obj":"Sentence"},{"id":"T61","span":{"begin":366,"end":444},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"For the biosafety-level (BSL) applied for inactivation of clinical samples suspected of 2019-nCoV, 22 laboratories of the 47 EU/EEA laboratories indicated to do this at BSL2. Twenty-one laboratories indicated to do so at BSL3. Four laboratories indicated an intermediate level BSL2 + (BSL2 with extra precautions such as wearing a filtering face piece (FFP)2 mask). Different approaches were observed between laboratories within some countries."}